Post #55 COVID-19 Vaccine for 12 to 15 Year Old Adolescents

The Pfizer vaccine will soon be offered to 12-15 year olds, raising a mild conundrum for parents.Should they skip the vaccine, given that most children have fared well when infected with COVID-19 (many already having been infected)?  Or should they immunize their child(ren), even though the vaccine is relatively new and doesn ’t have a long track record?Vaccines have had their missteps, most notably the recalled RotaShield immunization in 1999. However, the recall of RotaShield and the recent temporary pause of the Johnson&Johnson COVID-19 vaccine should instill confidence in the robustness and capability of the Vaccine Adverse Event Reporting System.255 million doses of the COVID-19 vaccine have been given in the United States to date, with over one-third of the population being fully vaccinated. 1 out of 3 people you see today will be fully vaccinated, and if the immunizations were causing serious side effects, the data should have captured it by now.In March, Pfizer reported results from a study with 2,260 children ages 12 to 15. None who received the vaccine contracted COVID-19. There were 18 cases of COVID-19 among children who received the placebo.Thevaccine works in adolescents.I recently attended to a 15 year old male varsity soccer player with no past medical history, who ended up in the ICU for 10 days due to COVID-19 pneumonia. Thankfully, he survived. The vaccine would have prevented this.There have been over 275 deaths in children 18 years and you...
Source: A Pediatrician's Blog - Category: Pediatrics Source Type: blogs

Related Links:

Comp Med. 2021 Sep 17. doi: 10.30802/AALAS-CM-21-000011. Online ahead of print.ABSTRACTThe coronavirus disease 2019 (COVID-19) pandemic was caused by a novel coronavirus, severe acute respiratory syndromecoronavirus 2 (SARS-CoV-2). This virus has challenged civilization and modern science in ways that few infectious diseases and natural disasters have previously, causing globally significant human morbidity and mortality and triggering economic downturns across financial markets that will be dealt with for generations. Despite this, the pandemic has also brought an opportunity for humanity to come together and participate ...
Source: Comparative Medicine - Category: Zoology Authors: Source Type: research
‘Coronavirus Disease 2019’ (COVID-19), caused by the highly transmissible and pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has so far infected about 220 million people worldwide, leading to more than 4.6 million deaths within a period of 21 months. In Thailand, approxi mately 1.3 million cases and over 13,000 deaths have been confirmed at the time of writing (2021). The ongoing COVID-19 pandemic has taken a significant toll on global public health and economy, calling for a deeper understanding of immune correlates of protection against SARS-CoV-2 that may be vita l for implementation...
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Source Type: research
Trop Biomed. 2021 Sep 1;38(3):343-352. doi: 10.47665/tb.38.3.077.ABSTRACTOutbreak of SARS-CoV-2 has been declared a pandemic, which is a serious threat to human health. The disease was named coronavirus disease 2019 (COVID-19). Until now, several vaccines and a few drugs have been approved for the prevention and treatment for COVID-19. Recently, the effect of some macrolides including clarithromycin (CAM) on COVID-19 has attracted attention. CAM is known to have diverse effects including immunomodulatory and immunosuppressive effects, autophagy inhibition, steroid sparing effect, reversibility of drug resistance, antineopl...
Source: Tropical Biomedicine - Category: Tropical Medicine Authors: Source Type: research
Summary: The novel coronavirus, severe acute respiratory syndrome coronavirus 2, responsible for the coronavirus disease of 2019 (COVID-19) pandemic, has claimed over 2 million lives to date and brought the global economy to a halt, including elective surgery. As the authors emerge from lockdown, new protocols must be implemented to minimize risk by means of appropriate screening of their patients, surgical adjustments to reduce viral transmission in case of undiagnosed infection, and the development of accurate severe acute respiratory syndrome coronavirus 2 tests while awaiting the distribution of an effective vaccin...
Source: Plastic and Reconstructive Surgery - Category: Cosmetic Surgery Tags: Plastic Surgery Focus: Special Topics Source Type: research
Expert Rev Mol Diagn. 2021 Aug 19. doi: 10.1080/14737159.2021.1970535. Online ahead of print.ABSTRACTINTRODUCTION: Emerging novel infectious diseases and persistent pandemics with potential to destabilize normal life remain a public health concern for the whole world. The recent outbreak of pneumonia caused by Coronavirus infectious disease-2019 (COVID-19) resulted in high mortality due to a lack of effective drugs or vaccines. With a constantly increasing number of infections with mutated strains and deaths across the globe, rapid, affordable and specific detections with more accurate diagnosis and improved health treatme...
Source: Expert Review of Molecular Diagnostics - Category: Laboratory Medicine Authors: Source Type: research
Cardiol J. 2021 Aug 12. doi: 10.5603/CJ.a2021.0088. Online ahead of print.ABSTRACTThe coronavirus pandemic disease 2019 (COVID-19) has changed the face of contemporary medicine. However, each and every medical practitioner must be aware of potential early and late complications of COVID-19, its impact on chronic diseases - especially ones as common as atrial fibrillation (AF) - and the possible interactions between patients' chronic medications and pharmacotherapy of COVID-19. Patients with AF due to comorbidities and, often, elderly age are assumed to be at a higher risk of a severe course of COVID-19. This expert consens...
Source: Cardiology Journal - Category: Cardiology Authors: Source Type: research
More News: Blogging | Children | Clinical Trials | COVID-19 | Pandemics | Pediatrics | Pfizer | Pneomococcal Vaccine | Pneumonia | Study | USA Health | Vaccines